COVID-19 is an emerging, rapidly evolving situation.

  • Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
  • Applicant/Recipient COVID-19 Update History
Expand for resources
  • U.S. Department of Health & Human Services
  • National Institutes of Health
Grants and Funding logo
  • eRA  |  NIH Staff onlyNIH Staff Lock Icon  |  Glossary  |  FAQs  |  Help
  • Home
  • About Grants
    • Grants Process Overview
    • Get Started

    • Learn the Basics
    • Plan Your Application
    • How to Apply

    • Prepare to Apply
    • Write Application
    • Submit
    • How to Apply Video Tutorials

      Application Referral and Review

    • Receipt and Referral
    • Peer Review
    • Pre-Award and Post-Award Processes

    • Pre-Award and Award Process
    • Post Award Monitoring and Reporting
    • Forms Library

      Information For

    • Researchers
    • Research Administrators
    • Reviewers
    • Small Businesses Link to External Site
    • Foreign Grants
    • Media and the Public
    • NIH Staff Lock Icon
  • Funding
    • Find Funding (NIH Guide to Grants and Contracts)
    • Contracts
    • Research Training and Career Development Link to External Site
    • Loan Repayment Programs Link to External Site
    • Extramural Diversity Link to External Site
    • NIH Funding Strategies




      Notice IconAvoid Grant Scams
  • Policy & Compliance
    • NIH Grants Policy Statement
    • Notices of Policy Changes
    • Compliance & Oversight
    • Policy Topics

    • Animal Welfare Link to External Site
    • Anti-Sexual Harassment
    • Application Submission Policies
    • Clinical Trial Requirements
    • Early Stage and Early Established Investigator Policies
    • Family-Friendly Initiatives
    • Financial Conflict of Interest
    • Human Subjects Research
    • Inclusion Policies
    • Intellectual Property Policy
    • Lobbying Guidance for Grantee Activities
    • Natural Disasters
    • NIH Funding Strategies
    • Peer Review Policies and Practices
    • Protecting U.S. Biomedical Intellectual Innovation
    • Public Access Link to External Site
    • Research Integrity
    • Resources to Evaluate Workplace Climate
    • Rigor and Reproducibility
    • Sharing Policies
  • News & Events

      Latest News

    • News Highlights
    • "Open Mike" Blog Link to External Site
    • Extramural Nexus Link to External Site
    • Subscribe and Follow

    • Listservs
    • Social Media

      Virtual Learning

    • Webinars
    • Podcasts
    • NIH Grants YouTube Channel Link to External Site

      Connect In Person

    • NIH Regional Seminars on Program
      Funding & Grants Administration
    • SBIR-STTR Engage & Connect Link to External Site
    • Loan Repayment Program (LRP)
      Contact & Engage
       Link to External Site
    • Office of Laboratory Animal Welfare (OLAW)
      Workshops and Conference
      Link to External Site
    • Events Calendar
  • About OER
    • About the Office of Extramural Research
    • OER Offices

    • Immediate Office of the Director (IMOD)
    • Office of Policy for Extramural Research Administration (OPERA)
    • Office of Research Information Services (ORIS)
    • Office of Laboratory Animal Welfare (OLAW)
    • Strategic Management and Contracts Office
    • Office of Electronic Research Administration (eRA)
    • Division of Communication & Outreach (DCO)
    • Small Business Education and Entrepreneurial Development (SEED)
    • Division of Biomedical Research Workforce (DBRW)
    • Division of Human Subjects Research
    • NIH Guide
    • Vacancies
  • eRA
    Link to External Site
  • NIH Staff Lock Icon
  • Home
  • FAQs
  • Help
Home

Funding Opportunities Specific to COVID-19

This page contains a listing of active and expired funding opportunities specific to Coronavirus Disease 2019 (COVID-19).

On This Page:

  • Active Funding Opportunities
  • Expired Funding Opportunities

Active Funding Opportunities

Title Notice Number Organization(s) Release
Date
Expiration
Date
Activity
Code(s)
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy NOT-GM-21-021 NIGMS, SGMRO Mar 1, 2021 May 1, 2021 333
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy NOT-GM-21-021 NIGMS, SGMRO Mar 1, 2021 May 1, 2021 333
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs NOT-TR-21-022 NCATS Feb 26, 2021 Aug 17, 2024 333
Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration NOT-AG-21-016 NIA Feb 26, 2021 May 8, 2023 R01, R21, R03
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 NOT-GM-21-019 NIGMS Feb 25, 2021 Dec 16, 2021 333
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 NOT-GM-21-019 NIGMS Feb 25, 2021 Dec 16, 2021 333
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies NOT-GM-21-031 NIGMS Feb 18, 2021 Apr 1, 2021 333
Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders NOT-DA-21-019 NIDA Feb 10, 2021 Sep 8, 2024 R01, R03, R21
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) RFA-AA-21-003 NIAAA Feb 5, 2021 Apr 15, 2021 R03
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) RFA-AA-21-003 NIAAA Feb 5, 2021 Apr 15, 2021 R03
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) RFA-AA-21-002 NIAAA Feb 5, 2021 Apr 15, 2021 R01
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) RFA-AA-21-002 NIAAA Feb 5, 2021 Apr 15, 2021 R01
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) RFA-AA-21-004 NIAAA Feb 5, 2021 Apr 15, 2021 R21
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) RFA-AA-21-004 NIAAA Feb 5, 2021 Apr 15, 2021 R21
Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19 NOT-DA-21-017 NIDA Feb 4, 2021 Sep 8, 2024 R01, R03, R21
Notice of Special Interest (NOSI): Complement in Basic Immunology (CIBI) NOT-AI-21-008 NIAID Feb 4, 2021 Jan 8, 2023 R01, R21
Notice of Special Interest (NOSI): Urgent Competitive Revisions and Administrative Supplements for Research at NIMHD Research Centers in Minority Institutions (RCMI U54s) on SARS-CoV-2 Vaccine Hesitancy, Uptake, and Implementation NOT-MD-21-012 NIMHD Feb 4, 2021 May 4, 2021 333
Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders NOT-DA-21-018 NIDA Feb 3, 2021 Sep 8, 2024 R01, R03, R21
Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Study the Impact of COVID-19 on Global Cancer Prevention and Control NOT-CA-21-033 NCI Feb 3, 2021 Apr 1, 2021 333
Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs NOT-TR-21-017 NCATS Feb 3, 2021 Aug 17, 2024 333
Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) NOT-DE-21-001 NIDCR Jan 26, 2021 May 8, 2023 R01, R21
Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19) NOT-AG-21-015 NIA Jan 26, 2021 May 8, 2023 R01, R03, R21, U19, P01, R21/R33
Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection NOT-DA-21-011 NIDA Jan 26, 2021 Sep 8, 2024 R01, R03, R21
Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed) RFA-AI-20-078 NIAID, NIEHS Jan 12, 2021 Jun 5, 2021 U19
Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) RFA-AI-20-077 NIAID, NIEHS Jan 12, 2021 Jun 5, 2021 U01
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases NOT-AR-21-012 NIAMS Jan 5, 2021 Nov 19, 2021 R01, R21
Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research NOT-MH-21-120 NIMH Dec 23, 2020 Jun 2, 2023 333
Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities NOT-MD-21-008 NIMHD, NCI, NHLBI, NIAAA, NIAID, NIAMS, NIDCR, NIMH, NINR, OBSSR, ODP, ORWH Dec 17, 2020 Jan 8, 2022 R01
Notice of Special Interest (NOSI): Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs NOT-TR-21-011 NCATS Dec 17, 2020 Jun 2, 2021 333
Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects NOT-AI-21-002 NIAID Nov 10, 2020 Jun 12, 2021 P01
Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection NOT-DA-20-084 NIDA Oct 27, 2020 Sep 8, 2024 R01, R03, R21
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) NOT-TR-21-006 NCATS Oct 23, 2020 Mar 17, 2021 UH2, U34, U01
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) NOT-TR-21-006 NCATS Oct 23, 2020 Mar 17, 2021 UH2, U34, U01
Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) NOT-HL-20-814 NHLBI Sep 15, 2020 Jul 6, 2024 R01
Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 NOT-AI-20-065 NIAID Aug 13, 2020 Mar 15, 2021 U01
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities NOT-MD-20-025 NIMHD, NCI, NIDA, NLM, ODP, OBSSR, NIMH, NIAMS Aug 13, 2020 May 8, 2023 R01
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) PAR-20-256 NIAID Jul 13, 2020 Jul 8, 2021 S10
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-AI-20-059 NIAID Jul 6, 2020 Jul 2, 2021 333
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project NOT-OD-20-129 NIH, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIAID, NIAMS, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NIMHD, NINDS, ORIP Jun 25, 2020 Jul 13, 2021 333
Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders NOT-DC-20-008 NIDCD Jun 4, 2020 Sep 8, 2022 R01, R21, R41/R42, R43/R44
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System NOT-NS-20-051 NINDS Apr 30, 2020 Apr 15, 2021 333
Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA NOT-AA-20-011 NIAAA Apr 16, 2020 Apr 16, 2021 333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences NOT-OD-20-097 OBSSR, NCCIH, NCI, NHGRI, NHLBI, NIAAA, NICHD, NIDDK, NIEHS, NINR, ODP, ORWH Apr 13, 2020 Apr 1, 2021 333
Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) NOT-ES-20-020 NIEHS Apr 10, 2020 May 4, 2021 333, R21
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities NOT-MD-20-019 NIMHD, NIAAA, NIMH, ODP Apr 9, 2020 May 1, 2021 333
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus NOT-TR-20-017 NCATS Apr 9, 2020 Jan 26, 2022 333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus NOT-MH-20-047 NIMH, NIAAA, ODP Apr 9, 2020 Apr 16, 2021 333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus NOT-TR-20-016 NCATS Apr 9, 2020 Jan 26, 2022 333
Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) NOT-ES-20-015 NIEHS Apr 8, 2020 May 4, 2021 333, R21
Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NOT-AG-20-022 NIAAA, NIMH Apr 2, 2020 May 1, 2021 333
RESCINDED - Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-AI-20-031 NIAID Mar 27, 2020 Apr 5, 2021 R03, R21, 333, R01, R43/R44, R41/R42
Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need NOT-TR-20-011 NCATS Mar 24, 2020 Jul 10, 2021 333, U01, R21, U54
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus NOT-DA-20-047 NIDA Mar 19, 2020 Mar 31, 2021 333
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) PA-20-135 NIH, NCATS, NCCIH, NCI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINR, NLM, ORWH, OSC Mar 10, 2020 Sep 8, 2025 333
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) RFA-OD-19-029 ORWH, NCCIH, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIDA, NIDCR, NIEHS, NIMH, NINR Sep 27, 2019 Nov 27, 2021 R01

Expired Funding Opportunities

Title Notice Number Organization(s) Release
Date
Expiration
Date
Activity
Code(s)
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed) NOT-AA-21-003 NIAAA Jan 27, 2021 Feb 28, 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed) NOT-AA-21-003 NIAAA Jan 27, 2021 Feb 28, 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trials Not Allowed) NOT-AA-21-002 NIAAA Jan 27, 2021 Feb 3, 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed) NOT-AA-21-001 NIAAA Jan 27, 2021 Feb 28, 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed) NOT-AA-21-001 NIAAA Jan 27, 2021 Feb 28, 2021
Notice of Special Interest (NOSI): Urgent Competitive Revisions for Research on Critical Threats to Public Health in Large-Scale Population Cohorts NOT-HG-21-020 NHGRI Dec 10, 2020 Jan 16, 2021 333
Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities NOT-MD-21-007 NIMHD Dec 7, 2020 Dec 31, 2020
Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad) NOT-OD-21-035 NIH, NIDCR, NHLBI Nov 25, 2020 Dec 5, 2020 333
Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) NOT-OD-21-020 NIH, NLM, NIEHS, NIAMS, NIDCR, OBSSR, NIGMS, NHLBI, NCI, NIAAA, NINR, NCATS, ORWH, NHGRI, FIC, NCCIH, NIMH, THRO, NIDA, NINDS, NEI, NIMHD, NIAID, NIA, FDA, NIBIB, NIDCD, NICHD, NIDDK Nov 17, 2020 Mar 5, 2021 333
Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities NOT-ES-21-002 NIEHS Nov 17, 2020 Dec 30, 2020 333
Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities NOT-ES-21-002 NIEHS Nov 17, 2020 Dec 30, 2020 333
Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) RFA-OD-20-023 NIH, FIC, NCATS, NHLBI, NIAID, NIAMS, NICHD, NIDA, NIMHD Aug 6, 2020 Oct 1, 2020 R61/R33
Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) RFA-OD-20-022 NIH, NIA, NIDCD, ORWH, NICHD, NLM, NINR, NINDS, NIDCR Aug 6, 2020 Sep 16, 2020 U01
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed) RFA-OD-20-021 NIH, NIAAA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR Aug 6, 2020 Sep 19, 2020 R42
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed) RFA-OD-20-020 NIH, NIAAA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR Aug 6, 2020 Sep 19, 2020 R44
Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) RFA-OD-20-019 NIH, NIAAA, NIA, NCCIH, NIDCD, NIDDK, NIEHS, NIGMS, NICHD, NIMHD, NLM, NINR, NCATS, OBSSR, NHLBI, NIDCR, NIDA Aug 6, 2020 Oct 1, 2020 U24
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) RFA-OD-20-018 NIH, NIA, NCI, RM, NCATS, NHLBI, NIDCR, NIDA, NHGRI Aug 6, 2020 Sep 19, 2020 U18
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) RFA-OD-20-018 NIH, NIA, NCI, RM, NCATS, NHLBI, NIDCR, NIDA, NHGRI Aug 6, 2020 Sep 19, 2020 U18
Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed) RFA-OD-20-017 NIH, NIAAA, NIA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR Aug 6, 2020 Sep 19, 2020 U18
Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) RFA-OD-20-016 NIH, NIAAA, NIDDK, NIGMS, NIMHD, NLM, NINR, OBSSR, NIDCR, NIDA Aug 6, 2020 Oct 1, 2020 R01
Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed) RFA-OD-20-015 NIH, NIEHS, NIGMS, NLM, NIDA Aug 6, 2020 Sep 16, 2020 U01
Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed) RFA-OD-20-014 NIH, NIAAA, NIA, NCCIH, NCI, NICHD Aug 6, 2020 Sep 16, 2020 U01
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool NOT-OD-20-152 NIH, NIA, NIDCD, ORWH, NICHD, NINR, NINDS, NIDCR Aug 6, 2020 Sep 16, 2020 333
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19). NOT-OD-20-159 NIH, NLM Aug 6, 2020 Aug 22, 2020 333
Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) RFA-TR-20-003 NCATS Aug 5, 2020 Jan 24, 2021 U01
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-rad Initiative NOT-OD-20-144 NIH, NIDCD Jul 10, 2020 Aug 6, 2020
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) RFA-DK-20-021 NIDDK Jul 10, 2020 Dec 17, 2020 R01
Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) NOT-CA-20-082 NCI Jul 6, 2020 Aug 15, 2020 333
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) PAR-20-243 NIMH, NCCIH, NEI, NIA, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIMHD, NINR, OBSSR, ODP, ORWH Jun 25, 2020 Mar 3, 2021 R01
Request for Proposals (RFP) Solicitation S20-119: Serological Sciences Network Capacity Building Centers NOT-CA-20-077 NCI Jun 25, 2020 Jul 31, 2020
Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) PAR-20-237 NIMHD, NIDCD, NIMH, ODP, NINR, NIA, SGMRO, NIDDK, NIEHS, NICHD, NCATS, ORWH, NIAAA, NCCIH, NIDA, NEI, NIDCR Jun 17, 2020 Dec 2, 2020 R01
Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need NOT-TR-20-029 NCATS Jun 15, 2020 Nov 11, 2020 333
NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) PAR-20-234 NIA Jun 15, 2020 Feb 2, 2021 R01
Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations NOT-OD-20-121 NIH, NIDCR, NICHD, NCI, NCATS, NEI, NHLBI, NIAID, NIAMS, NIDDK, NIEHS, NIGMS, NHGRI, NIMH, NINDS, NINR, NIAAA, NIDA, NIMHD, ORWH, OBSSR, NLM, SGMRO, THRO, NIA, NCCIH, ODP Jun 12, 2020 Aug 8, 2020 333
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations NOT-OD-20-120 NIH, NIAID, NIBIB, NIDCR, NIMHD, NICHD, NIAMS, FIC, NCI, NCATS, NCCIH, NEI, NHLBI, NIDDK, NIEHS, NIGMS, NHGRI, NIMH, NINDS, NINR, NIAAA, NIA, NIDCD, NIDA, ORWH, OBSSR, ODP, NLM, SGMRO, THRO Jun 12, 2020 Sep 9, 2020 333
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations NOT-OD-20-119 NIH, NICHD, FIC, NCI, NCATS, NCCIH, NEI, NHLBI, NIAID, NIAMS, NIBIB, NIDCR, NIDDK, NIEHS, NIGMS, NHGRI, NIMH, NINDS, NINR, NIA, NIAAA, NIDA, NIMHD, ORWH, ODP, NLM, SGMRO, THRO, NIDCD, OBSSR Jun 12, 2020 Sep 9, 2020 333
Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) RFA-OD-20-013 NIH, NCI, NIAMS, NIA, NICHD, FIC, NCATS, NCCIH, NEI, NHLBI, NIBIB, NIDCR, NIEHS, NIGMS, NHGRI, NIMH, NINR, NIDCD, NIDA, NIMHD, ORWH, OBSSR, NLM, SGMRO, THRO, ODP Jun 12, 2020 Aug 8, 2020 U24
Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) RFA-CA-20-038 NCI, NIAID Jun 5, 2020 Jul 23, 2020 U54
Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) RFA-CA-20-039 NCI, NIAID Jun 5, 2020 Jul 23, 2020 U01
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations NOT-MD-20-022 NIMHD, ORWH, NCATS, NCCIH, NEI, NHLBI, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, OBSSR, ODP Jun 5, 2020 Dec 30, 2020 333
Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 NOT-MH-20-053 NIMH, NCATS, NCCIH, NEI, NHLBI, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NINR, OBSSR, ODP, ORWH Jun 5, 2020 Dec 30, 2020 333
Notice of Intent to Publish a Funding Opportunity Announcement for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional) NOT-MH-20-058 NIMH, NIAAA, NIA, NCCIH, NIDCD, NICHD, NINR, OBSSR, ODP, NIDCR, NIDA, NEI Jun 4, 2020 Jun 26, 2020
Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) NOT-MD-20-023 NIMHD, NIDCD, OBSSR, NIDA, NINR, ODP, NCCIH, NIMH, NIDCR, NIEHS, NIA, NICHD, ORWH Jun 3, 2020 Jun 17, 2020
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives NOT-OD-20-112 NIH May 29, 2020 Jun 26, 2020
Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19) related Research NOT-OD-20-107 NIH May 27, 2020 Jun 30, 2020 333
Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) NOT-AT-20-012 NCCIH May 26, 2020 Aug 18, 2020 333
NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional) RFA-RM-20-020 RMOD May 21, 2020 Oct 1, 2020 R01
NIH Directors Emergency Early Independence Awards (DP5 Clinical Trial Optional) RFA-RM-20-021 RMOD May 21, 2020 Sep 5, 2020 DP5
Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-AI-20-051 NIAID May 19, 2020 Sep 8, 2020 R03,R43/R44,R41/R42
Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence NOT-CA-20-066 NCI May 15, 2020 Jun 5, 2020
Notice of Special Interest (NOSI):? Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR NOT-DE-20-022 NIDCR, ORWH May 5, 2020 Nov 3, 2020 333
Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network NOT-DE-20-023 NIDCR May 1, 2020 Nov 3, 2020 X01
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) PAR-20-177 NIAID Apr 30, 2020 Aug 14, 2020 R21
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) PAR-20-178 NIAID Apr 30, 2020 Aug 14, 2020 R01
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials NOT-HL-20-782 NHLBI Apr 27, 2020 Oct 6, 2020 333
Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21) NOT-LM-20-011 NLM Apr 27, 2020 Jun 17, 2020 R21
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-RM-20-015 RMOD Apr 27, 2020 Jun 20, 2020 333
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs NOT-TR-20-028 NCATS Apr 23, 2020 Nov 11, 2020 333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) NOT-LM-20-010 NLM Apr 16, 2020 Jun 2, 2020 333
Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) NOT-EB-20-007 NIBIB Apr 10, 2020 Aug 29, 2020 R01,R21,R03
Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 NOT-GM-20-027 NIGMS Apr 10, 2020 May 6, 2020 333
NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) NOT-ES-20-017 NIEHS Apr 10, 2020 Apr 25, 2020 333
Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) NOT-EB-20-006 NIBIB Apr 10, 2020 Sep 6, 2020 R41/R42,R43/R44
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) NOT-EB-20-008 NIBIB Apr 10, 2020 Aug 29, 2020 333
Notice of Special Interestregarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2 NOT-NS-20-046 NINDS Apr 10, 2020 May 9, 2020 333
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission NOT-DK-20-020 NIDDK Apr 9, 2020 Jun 2, 2020 333
Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) NOT-CA-20-043 NCI Apr 9, 2020 Jun 26, 2020 333
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK NOT-DK-20-018 NIDDK Apr 9, 2020 Jun 2, 2020 333
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) NOT-DC-20-004 NIDCD Apr 9, 2020 Jun 2, 2020 333
Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) NOT-AT-20-011 NCCIH, NIA, NIAAA, ODP Apr 9, 2020 Oct 7, 2020 333
Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) NOT-CA-20-042 NCI Apr 9, 2020 Jun 26, 2020 333
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus NOT-HG-20-030 NHGRI Mar 31, 2020 May 16, 2020 333
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) NOT-TR-20-012 NCATS Mar 27, 2020 Oct 17, 2020 UH2,U01,U34
RESCINDED - Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) NOT-ES-20-014 NIEHS Mar 27, 2020 Apr 25, 2020 333
RESCINDED - Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-AI-20-034 NIAID Mar 25, 2020 Jul 6, 2020 333
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 NOT-GM-20-025 NIGMS Mar 25, 2020 Feb 6, 2021 333
RESCINDED - Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NOT-HL-20-757 NHLBI Mar 17, 2020 May 15, 2020 333
RESCINDED - Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) NOT-AI-20-030 NIAID, NIGMS Feb 6, 2020 Apr 8, 2020 333
Notice of Special Interest: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) NOT-OD-20-048 ORWH, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD Dec 13, 2019 Jan 26, 2021 333


Technical Issues: E-mail OER Webmaster   

Back to Top
  • Contact Us
  • Bookmark & Share
  • E-mail Updates
  • RSS Feed
  • Podcast
  • Twitter
  • Youtube

  • Search Link to External Site
  • Help Downloading Files
  • Disclaimer
  • Older Versions of this Page Link to External Site
  • Privacy Notice
  • Accessibility
  • FOIA Link to External Site
  • U.S. Department of Health and Human Services Link to External Site
  • Grants.gov Link to External Site
  • USA.gov - Government Made Easy Link to External Site


  • National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892

  • NIH... Turning Discovery Into Health